J. Leja-Jarblad

Shaping the Tumor Stroma and Sparking Immune Activation by CD40 and 4-1BB Signaling Induced by an Armed Oncolytic Virus

R. Alemany, G. Ullenhag, A. Dimberg, 2017, Clinical Cancer Research.

Extracorporeal human whole blood in motion, as a tool to predict first‐infusion reactions and mechanism‐of‐action of immunotherapeutics

M. Eltahir, S. Mangsbo, E. Fletcher, 2018, International immunopharmacology.

Preclinical Evaluation of AdVince, an Oncolytic Adenovirus Adapted for Treatment of Liver Metastases from Neuroendocrine Cancer

M. Essand, P. Hellman, K. Oberg, 2016, Neuroendocrinology.

Safe and Effective Treatment of Experimental Neuroblastoma and Glioblastoma Using Systemically Delivered Triple MicroRNA-Detargeted Oncolytic Semliki Forest Virus

S. Nelander, M. Essand, A. Merits, 2016, Clinical Cancer Research.

LOAd703, an oncolytic virus-based immunostimulatory gene therapy, combined with chemotherapy for unresectable or metastatic pancreatic cancer (LOKON001): results from arm 1 of a non-randomised, single-centre, phase 1/2 study.

A. Leen, Benjamin L. Musher, Linda C. Sandin, 2024, The Lancet. Oncology.